CytoCore, Inc. Product Pipeline Analysis

SUMMARY

CytoCore, Inc. Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a CytoCore, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Reasons to buy

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

TABLE OF CONTENTS

1 Table of Contents 3
1.1 List of Tables 6
1.2 List of Figures 7
2 Company Snapshot 8
2.1 Key Information 8
2.2 Company Overview 8
2.3 Industry Outlook -- In Vitro Diagnostics 8
3 Business Description 9
3.1 Business Overview 9
3.2 Major Products and Services 9
3.2.1 Overview 9
4 History 10
5 Competitors 11
6 Key Employees 12
7 Key Employee Biographies 13
8 Company Statement 15
9 Locations And Subsidiaries 17
9.1 Head Office 17
10 Recent Developments 18
10.1 Financial Announcements 18
10.1.1 Aug 12, 2008: CytoCore Reports 2Q 2008 Results 18
10.1.2 May 20, 2008: CytoCore Declares Q1 2008 Results 19
10.1.3 Apr 03, 2008: CytoCore Declares 2007 Results 20
10.1.4 Nov 16, 2007: CytoCore Declares Q3 2007 Results 21
10.1.5 Aug 20, 2007: CytoCore Declares Q2 2007 Results 22
10.1.6 Apr 19, 2007: CytoCore Declares Full Year 2006 Results 22
10.2 Corporate Communications 23
10.2.1 May 02, 2008: CytoCore Announces Management Appointments 23
10.2.2 Dec 28, 2007: CytoCore Appoints President, International Operations 23
10.2.3 Oct 23, 2007: CytoCore Appoints CEO 24
10.2.4 Oct 23, 2007: CytoCore Appoints New COO, CEO 24
10.2.5 Oct 04, 2007: CytoCore Appoints Director, Assay Development 24
10.2.6 Aug 28, 2007: CytoCore Appoints Director, Marketing 24
10.2.7 Jul 12, 2007: CytoCore Appoints New CEO 25
10.3 Product News 25
10.3.1 Apr 07, 2008: CytoCore Reports On Interim Trial Results 25
10.3.2 Mar 26, 2008: CytoCore Enters Into An Additional International Distribution Agreement For SoftPAP 25
10.3.3 Mar 17, 2008: CytoCore Enters Into Distribution Agreement With CoMedical For SoftPAP Cell Collectors 26
10.3.4 Feb 21, 2008: CytoCore Launches SoftPAP Cervical Cell Collector In Spain 26
10.4 Clinical Trials 26
10.4.1 Apr 07, 2008: CytoCore Reports On Interim Trial Results 26
10.5 Other Significant Developments 26
10.5.1 Mar 17, 2008: CytoCore Signs Distribution Agreement With CoMedical 26
10.5.2 Nov 28, 2007: Cytocore Announces New Trading Symbol CYOE 27
11 CytoCore, Inc. Pipeline Products 28
11.1 CytoCore, Inc. Product Pipeline Analysis 28
11.1.1 CytoCore, Inc. Pipeline Products By Equipment Type 28
11.1.2 CytoCore, Inc. Pipeline Products By Development Stage 29
11.1.3 CytoCore, Inc. Pipeline Products By Therapy Area 30
11.1.4 CytoCore, Inc. Pipeline Products By Clinical Trials 30
11.2 Cocktail-CVX Biochemical assay 30
11.2.1 Product Description 30
11.2.2 Product Status 30
11.3 Cocktail-GCI Biochemical Assay 31
11.3.1 Product Description 31
11.3.2 Product Status 31
11.3.3 Clinical Trials 31
11.4 Slide Based Test for Endometrial cancer 32
11.4.1 Product Description 32
11.4.2 Product Status 33
11.4.3 Clinical Trials 33
11.5 Slide based test for Cervical cancer 34
11.5.1 Product Description 34
11.5.2 Product Status 34
11.6 Automated Imaging Proteomic System 34
11.6.1 Product Description 34
11.6.2 Product Status 35
12 Appendix 36
12.1 Methodology 36
12.1.1 Coverage 36
12.1.2 Secondary Research 37
12.1.3 Primary Research 37
12.1.4 Expert Panel Validation 38
12.2 Contact Us 38
12.3 About Global Markets Direct 38
12.4 Disclaimer 38

1.1 List of Tables
Table 1: CytoCore, Inc.,Key Facts 8
Table 2: CytoCore, Inc., Key Employees, 12
Table 3: CytoCore, Inc. Pipeline Products by Equipment Type 28
Table 4: CytoCore, Inc. Pipeline Products By Development Stage 29
Table 5: CytoCore, Inc. Pipeline Products By Therapy Area 30
Table 6: CytoCore, Inc. Pipeline Products By Clinical Trials 30

1.2 List of Figures
Figure 1: CytoCore, Inc. Pipeline Products By Development Stage 29
Figure 2: Global Markets Direct Methodology 36